Medistar launches gammaCore™ Sapphire non-invasive vagus nerve stimulator (nVNS) in Australia, supplying therapy to patients suffering with primary headache disorders. The announcement follows the recent granting of regulatory approval from the Australian Therapeutic Goods Administration (TGA).

Read more here.